Published • loading... • Updated
Cancer, Breast: Fabi (Aiom), 'Good Use Genomic Test but Wide Margin of Improvement'
Summary by newsbiella.it
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
Rec News | Lontani dal mainstream+2 Reposted by 2 other sources
The results of the National Monitoring Centre on genomic tests are positive: doctors have managed to bring precision medicine to every hospital through the genomic test, learning to use it according to appropriate criteria in patients with an already operated ormono-dependent and Her2-negative early cancer, which represents about 60% of the cases of cancer at the [...] L'articolo Tumori, sine: Fabi (Aiom), "bene uso test genomico ma ampio margin…
(Adnkronos) - "The results" found by the National Observatory on genomic tests "are positive: doctors have managed to bring precision medicine to every hospital through the genomic test, learning how to...
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
